Differential white matter connectivity in early mild cognitive impairment according to CSF biomarkers

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Lim, Jae Sung ^a,c   Park, Young Ho ^b,c   Jang, Jae Won ^b,c   Park, So Yong ^b,c   Kim, Sang Yun ^b,c  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; ANILINE DERIVATIVE; BIOLOGICAL MARKER; ETHYLENE GLYCOL DERIVATIVE; FLORBETAPIR; TAU PROTEIN;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN REGION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; DISEASE MARKER; EDUCATIONAL STATUS; GENOTYPE; HUMAN; INFERIOR LONGITUDINAL BUNDLE; LACUNAR STROKE; MILD COGNITIVE IMPAIRMENT; PROTEIN PHOSPHORYLATION; SUPERIOR LONGITUDINAL BUNDLE; WHITE MATTER; CASE CONTROL STUDY; DRUG EFFECTS; FEMALE; MALE; NERVE CELL NETWORK; PATHOLOGY; PATHOPHYSIOLOGY;

AGED; ANILINE COMPOUNDS; BIOMARKERS; CASE-CONTROL STUDIES; ETHYLENE GLYCOLS; FEMALE; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; NERVE NET; TAU PROTEINS; WHITE MATTER;

EID: 84897551235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091400     Document Type: Article

References (38)

1. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256: 183-194. (Pubitemid 39222988)
2. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, et al. (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 270-279.
3. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, et al. (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 263-269.
4. Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, et al. (2012) Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry 69: 98-106.
5. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, et al. (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroim-aging initiative subjects. Ann Neurol 65: 403-413.
6. Parnetti L, Chiasserini D, Eusebi P, Giannandrea D, Bellomo G, et al. (2012) Performance of abeta1-40, abeta1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment. J Alzheimers Dis 29: 229-238.
7. Sjögren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, et al. (2001) Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem 47: 1776-1781. (Pubitemid 32881189)
8. Amlien IK, Fjell AM, Walhovd KB, Selnes P, Stenset V, et al. (2012) Mild Cognitive Impairment: Cerebrospinal Fluid Tau Biomarker Pathologic Levels and Longitudinal Changes in White Matter Integrity. Radiology 266: 295-303.
9. O'Dwyer L, Lamberton F, Bokde ALW, Ewers M, Faluyi YO, et al. (2011) Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer's disease. PLoS One 6: e21745.
10. ADNI (2011) ADNI-GO Procedures Manual. 83-86.
11. Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, et al. (2010) The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement 6: 202-211 e207.
12. Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17: 143-155. (Pubitemid 35253488)
13. Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM (2012) Fsl. Neuroimage 62: 782-790.
14. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, et al. (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31: 1487-1505.
15. Nichols TE, Holmes AP (2002) Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 15: 1-25. (Pubitemid 34020610)
16. Zhuang L, Wen W, Zhu W, Trollor J, Kochan N, et al. (2010) White matter integrity in mild cognitive impairment: A tract-based spatial statistics study. NeuroImage 53: 16-25.
17. Jack CR Jr, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, et al. (2012) An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol 71: 765-775.
18. Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, et al. (2012) Brain injury biomarkers are not dependent on beta-amyloid in normal elderly. Ann Neurol 73: 472-480.
19. Chetelat G (2013) Alzheimer disease: Abeta-independent processes-rethinking preclinical AD. Nat Rev Neurol 9: 123-124.
20. Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, et al. (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9: 119-128.
21. Clerx L, Visser PJ, Verhey F, Aalten P (2012) New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements. J Alzheimers Dis 29: 405-429.
22. Nir TM, Jahanshad N, Villalon-Reina JE, Toga AW, Jack CR, et al. (2013) Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. Neuroimage Clin 3: 180-195.
23. Fieremans E, Benitez A, Jensen JH, Falangola MF, Tabesh A, et al. (2013) Novel White Matter Tract Integrity Metrics Sensitive to Alzheimer Disease Progression. AJNR Am J Neuroradiol 34: 2105-2112.
24. Sexton CE, Kalu UG, Filippini N, Mackay CE, Ebmeier KP (2011) A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 32: 2322. e5-18.
25. Chua TC, Wen W, Slavin MJ, Sachdev PS (2008) Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review. Curr Opin Neurol 21: 83-092.
26. Arenaza-Urquijo EM, Bosch B, Sala-Llonch R, Sole-Padulles C, Junque C, et al. (2011) Specific anatomic associations between white matter integrity and cognitive reserve in normal and cognitively impaired elders. Am J Geriatr Psychiatry 19: 33-42.
27. Bozzali M, Parker GJ, Serra L, Embleton K, Gili T, et al. (2011) Anatomical connectivity mapping: a new tool to assess brain disconnection in Alzheimer's disease. Neuroimage 54: 2045-2051.
28. Benitez A, Fieremans E, Jensen JH, Falangola MF, Tabesh A, et al. (2013) White matter tract integrity metrics reflect the vulnerability of late-myelinating tracts in Alzheimer's disease. Neuroimage Clin 4: 64-71.
29. Dimitra S, Verganelakis DA, Gotsis E, Toulas P, Papatriantafillou J, et al. (2013) Diffusion tensor imaging (DTI) in the detection of white matter lesions in patients with mild cognitive impairment (MCI). Acta Neurol Belg 113: 441-451.
30. Thillainadesan S, Wen W, Zhuang L, Crawford J, Kochan N, et al. (2012) Changes in mild cognitive impairment and its subtypes as seen on diffusion tensor imaging. Int Psychogeriatr 24: 1483-1493.
31. Lehmann M, Ghosh PM, Madison C, Laforce R Jr, Corbetta-Rastelli C, et al. (2013) Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain 136: 844-858.
32. Esposito R, Mosca A, Pieramico V, Cieri F, Cera N, et al. (2013) Characterization of resting state activity in MCI individuals. PeerJ 1: e135.
33. Pievani M, de Haan W, Wu T, Seeley WW, Frisoni GB (2011) Functional network disruption in the degenerative dementias. Lancet Neurol 10: 829-843.
34. Landau SM, Lu M, Joshi AD, Pontecorvo M, Mintun MA, et al. (2013) Comparing PET imaging and CSF measurements of Ab. Ann Neurol doi: 10.1002/ana.23908.
35. Hampel H, Goernitz A, Buerger K (2003) Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein. Brain Res Bull 61: 243-253. (Pubitemid 36952470)
36. Chiang GC, Zhan W, Schuff N, Weiner MW (2012) White Matter Alterations in Cognitively Normal apoE e2 Carriers: Insight into Alzheimer Resistance? AJNR Am J Neuroradiol 33: 1392-1397.
37. Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, et al. (2007) Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 68: 288-291. (Pubitemid 46148341)
38. Albin RL, Burke JF, Koeppe RA, Giordani B, Gilman S, et al. (2013) Assessing mild cognitive impairment with amyloid and dopamine terminal molecular imaging. J Nucl Med 54: 887-893.